tiprankstipranks
Trending News
More News >
Cyfuse Biomedical K.K. (JP:4892)
:4892
Japanese Market

Cyfuse Biomedical K.K. (4892) Income Statement

Compare
0 Followers

Cyfuse Biomedical K.K. Income Statement

Last quarter (Q2 2025), Cyfuse Biomedical K.K.'s total revenue was ¥5.21M, a decrease of -28.64% from the same quarter last year. In Q2, Cyfuse Biomedical K.K.'s net income was ¥-239.53M. See Cyfuse Biomedical K.K.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 54.45M¥ 61.11M¥ 374.48M¥ 708.25M¥ 137.48M
Gross Profit
¥ 16.45M¥ 37.74M¥ 241.50M¥ 570.60M¥ 67.02M
Operating Expenses
¥ 912.00M¥ 735.18M¥ 666.59M¥ 500.03M¥ 439.16M
Depreciation and Amortization
¥ 36.02M¥ 38.12M¥ 54.28M¥ 18.50M¥ 32.89M
EBITDA
¥ -824.22M¥ -538.29M¥ -410.21M¥ 168.65M¥ -288.66M
Operating Income
¥ -896.13M¥ -697.44M¥ -425.09M¥ 70.57M¥ -372.13M
Other Income/Expenses
¥ 26.39M¥ 111.25M¥ -46.86M¥ 74.34M¥ 44.64M
Pretax Income
¥ -869.75M¥ -586.19M¥ -471.95M¥ 144.91M¥ -327.49M
Net Income
¥ -872.24M¥ -589.21M¥ -473.96M¥ 142.91M¥ -329.50M
Per Share Metrics
Basic EPS
¥ -108.31¥ -75.42¥ -177.67¥ 285.52¥ -46.12
Diluted EPS
¥ -108.31¥ -75.42¥ -177.67¥ 285.52¥ -46.12
Weighted Average Shares Outstanding
8.05M 7.81M 2.67M 500.50K 7.14M
Weighted Average Shares Outstanding (Diluted)
8.05M 7.81M 2.67M 500.50K 7.14M
Currency in JPY

Cyfuse Biomedical K.K. Earnings and Revenue History